APLN, apelin, 8862

N. diseases: 226; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE This study aims to investigate the interaction between apelin and AVP in osmotic regulation in type 2 diabetes mellitus (T2DM), and to explore the underlying mechanism. 30334404 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Apelin, as an adipokine, plays an important role in the pathogenesis of insulin resistance and type 2 diabetes. 31548844 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.100 AlteredExpression disease BEFREE In conclusion, PIO inhibited the expression of apelin in T2DM rat models to prevent diabetic macroangiopathy, and negatively regulated the gene transcription of apelin by promoting transcription of KLF4 in the apelin promoter. 31829402 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Our aim is to assess the effect of long-term apelin treatment on serum insulin level and pancreatic islet beta-cell mass in the late stage of type 2 diabetes without hyperinsulinemia and to investigate the role of apelin in myocardial fatty acid and glucose metabolism. 30954534 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE The primary analysis for the main hypothesis on a total number of 1102 cases and 1078 healthy control subjects found that the weighted pooled SMD for the impact of apelin blood concentration in type 2 diabetes mellitus was as follows: SMD = 2.136 (95% confidence interval, 1.580-2.693). 30583036 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE On the other hand, many animal models and clinical studies have demonstrated that apelin, an adipocytokine, is related to the obesity and T2DM. 29101069 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Overproduction of apelin in obesity could be one of the last protective defenses before type 2 diabetes develops. 28125271 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.100 AlteredExpression disease BEFREE In conclusion, the findings revealed that chronic exercise training, independently of body weight and fat pad weight by decrease of insulin resistance can increase apelin levels in visceral adipose tissue, thereby attenuating the progression of diabetes and decreasing insulin resistance in T2DM rats. 29626513 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Upregulated expression of resistin, vaspin, apelin and TNF-α plays a significant role in induction of insulin resistance linked with obesity and type 2 diabetes. 29229313 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.100 AlteredExpression disease BEFREE The aim of this study is to create a new approach to treat type 2 diabetes by inducing prolonged expression of apelin in Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs). 30526660 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Apelin‑13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high‑fat diet. 30387843 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Exercise-induced apelin as a myokine is believed to play a role in the improvement of type 2 diabetes mellitus (T2DM) and capillarization. 28164323 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Therefore, it is hypothesized that apelin, which is increased in plasma in type 2 diabetes, lead to podocyte apoptosis through inhibiting podocyte autophagy, which resulted in podocyte dysfunction followed by DN. 28837139 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation disease BEFREE The objective of the study was to analyze the association of apelin gene (APLN) single nucleotide polymorphisms (SNPs) and type 2 diabetes mellitus (T2DM). 27831922 2016
Diabetes Mellitus, Non-Insulin-Dependent
0.100 AlteredExpression disease BEFREE We have recently demonstrated that subjects with type 2 diabetes (T2D) have significantly higher serum apelin levels compared with controls, and that these levels associate with fasting glucose, basal disposition index, age, and diagnosis of T2D. 26789934 2016
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE The results showed that serum apelin was significantly higher in the patients with type 2 diabetes compared to healthy people (p<0.05, Fig. 23577111 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE Apelin mRNA is significantly higher expressed in adipose tissue of patients with type 2 diabetes and correlates with circulating apelin, BMI, body fat, C-reactive protein, and insulin sensitivity. 23429279 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.100 Biomarker disease BEFREE In this review, we describe the various metabolic functions that are affected by apelin and we present an integrated overview of recent findings that collectively propose apelin as a promising target for the treatment of T2DM. 22445464 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.100 AlteredExpression disease BEFREE However, the regulation of apelin and APJ (apelin receptor) expression in skeletal muscle in relation to insulin resistance or type 2 diabetes is not known. 20233941 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation disease BEFREE This study aimed to investigate the effects of apelin genetic variants on type 2 diabetes and related quantitative traits. 19567136 2009